Kandalaft LE - Search Results

1

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.

Mastelic-Gavillet B, Sarivalasis A, Lozano LE, Lofek S, Wyss T, Melero I, de Vries IJM, Harari A, Romero P, Kandalaft LE, Viganó S. Mastelic-Gavillet B, et al. Among authors: kandalaft le. Front Immunol. 2023 Feb 10;14:1119371. doi: 10.3389/fimmu.2023.1119371. eCollection 2023. Front Immunol. 2023. PMID: 36845155 Free PMC article.

2

Clinical translation section: accelerating the pace from bench to bedside.

Kandalaft LE, Coukos G. Kandalaft LE, et al. J Transl Med. 2011 Jul 21;9:116. doi: 10.1186/1479-5876-9-116. J Transl Med. 2011. PMID: 25928255 Free PMC article. No abstract available.

3

Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.

Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, Zhang D, Yuan H, Hua K, Lu Y, Katsaros D, Huang Q, Montone K, Fan Y, Coukos G, Boyd J, Sood AK, Rebbeck T, Mills GB, Dang CV, Zhang L. Yan X, et al. Among authors: kandalaft le. Cancer Cell. 2015 Oct 12;28(4):529-540. doi: 10.1016/j.ccell.2015.09.006. Cancer Cell. 2015. PMID: 26461095 Free PMC article.

4

Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures.

Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A, Gumbleton M. Campbell L, et al. Among authors: kandalaft le. J Pharmacol Exp Ther. 2003 Jan;304(1):441-52. doi: 10.1124/jpet.102.042994. J Pharmacol Exp Ther. 2003. PMID: 12490621

5

Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesis.

Kandalaft LE, Zudaire E, Portal-Núñez S, Cuttitta F, Jakowlew SB. Kandalaft LE, et al. Carcinogenesis. 2008 Jun;29(6):1282-9. doi: 10.1093/carcin/bgn087. Epub 2008 Apr 1. Carcinogenesis. 2008. PMID: 18381359 Free PMC article.

6

Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.

Siccardi D, Kandalaft LE, Gumbleton M, McGuigan C. Siccardi D, et al. Among authors: kandalaft le. J Pharmacol Exp Ther. 2003 Dec;307(3):1112-9. doi: 10.1124/jpet.103.056135. Epub 2003 Oct 13. J Pharmacol Exp Ther. 2003. PMID: 14557377

7

Expression and transport functionality of FcRn within rat alveolar epithelium: a study in primary cell culture and in the isolated perfused lung.

Sakagami M, Omidi Y, Campbell L, Kandalaft LE, Morris CJ, Barar J, Gumbleton M. Sakagami M, et al. Among authors: kandalaft le. Pharm Res. 2006 Feb;23(2):270-9. doi: 10.1007/s11095-005-9226-0. Epub 2006 Jan 1. Pharm Res. 2006. PMID: 16382279

8

Immunotherapy for ovarian cancer: recent advances and perspectives.

Zsiros E, Tanyi J, Balint K, Kandalaft LE. Zsiros E, et al. Among authors: kandalaft le. Curr Opin Oncol. 2014 Sep;26(5):492-500. doi: 10.1097/CCO.0000000000000111. Curr Opin Oncol. 2014. PMID: 25036883 Review.

9

Personalized approaches to active immunotherapy in cancer.

Ophir E, Bobisse S, Coukos G, Harari A, Kandalaft LE. Ophir E, et al. Among authors: kandalaft le. Biochim Biophys Acta. 2016 Jan;1865(1):72-82. doi: 10.1016/j.bbcan.2015.07.004. Epub 2015 Aug 1. Biochim Biophys Acta. 2016. PMID: 26241169 Review.

10

Cancer Vaccines in Ovarian Cancer: How Can We Improve?

Martin Lluesma S, Wolfer A, Harari A, Kandalaft LE. Martin Lluesma S, et al. Among authors: kandalaft le. Biomedicines. 2016 May 3;4(2):10. doi: 10.3390/biomedicines4020010. Biomedicines. 2016. PMID: 28536377 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page